FDA label

What is mycophenolate mofetil used for?

The FDA-approved uses of mycophenolate mofetil, quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label says: “Mycophenolate mofetil capsules (MMF) are indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants.”

Run it in Rivvi

Which 2027 plans near you dropped or restricted mycophenolate mofetil?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Mycophenolate Mofetil, capsule

Indications and Usage, quoted from the label by Teva Pharmaceuticals USA, Inc. (ANDA065491). Cross-references to other label sections are left out.

Mycophenolate mofetil capsules (MMF) are indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants.

Source: DailyMed label, set id b414303f-e6f3-4e22-a537-96be352b59a4, version 34, effective August 31, 2026. NDC 0093-7334, one of 19 listings for this product.

Mycophenolate Mofetil, tablet, film coated

Indications and Usage, quoted from the label by Camber Pharmaceuticals, Inc. (ANDA208119). Cross-references to other label sections are left out.

Mycophenolate mofetil tablets are indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies], heart [see Clinical Studies] or liver transplants [see Clinical Studies], in combination with other immunosuppressants.

Source: DailyMed label, set id c3ded171-89da-4644-9ee8-dbcf6258036f, version 2, effective January 13, 2026. NDC 31722-879, one of 18 listings for this product.

Questions

What is mycophenolate mofetil used for?

The FDA label says: “Mycophenolate mofetil capsules (MMF) are indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants.”

What drug class is mycophenolate mofetil?

FDA lists mycophenolate mofetil in the Antimetabolite Immunosuppressant established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Mycophenolate Mofetil

Try it on your own data today.

Free to start. Most teams are using it the same day.